What are the Pros and Cons of Owning Any Lab Test Now Franchise?
Decision answer
What are the verified pros and cons of Any Lab Test Now?
The strongest verified advantage is a defined operating system supported by format-specific training and unusually detailed 2025 gross-revenue disclosure. The strongest burden is the combined full-time management, approved-supplier, technology, marketing, and channel-control framework. These 2026 FDD trade-offs are conditional: they describe buyer fit and execution demands, not a buy-or-reject recommendation.
Data basis. The legal franchisor is Any Test Franchising, LLC, a Georgia limited liability company whose parent is Cresso Brands, LLC. The analysis uses the Franchise Disclosure Document issued April 20, 2026; the Stand-Alone and Micro Market formats; the Franchise Agreement and Multi-Unit Development Agreement; Items 1, 3–8, 10–12, 15–17, and 19–22; 2025 Item 19 reporting; and Item 20 outlet data for 2023–2025. Public pages were checked July 28, 2026.
39 hoursInitial classroom trainingOwner contact and designated staff attend.
110,001+Stand-Alone populationMicro Markets use smaller populations.
Evidence limit
The 2026 FDD lists the single-unit Micro Market range as $63,025–$252,525, while the current official franchise FAQ displays $73,225–$272,925, matching the FDD’s multi-unit Micro Market range. A buyer should obtain a written reconciliation for the exact format and agreement before relying on either figure.
Evidence-led trade-offs
Which features may help a buyer, and what constraints travel with them?
The relevant question is not how many advantages or disadvantages exist. It is whether the mechanism behind each obligation fits the buyer’s capital, management capacity, control preferences, market, and exit horizon.
Stand-Alone and Micro Market format choice
Verified fact: The FDD offers two population-based formats with different investment ranges, while Any Test Franchising, LLC provides no direct or indirect financing and guarantees no obligation.
Potential advantageMicro Market structure may suit smaller MSAs and buyers seeking a lower disclosed entry range.
ConstraintBuyers dependent on franchisor financing or a fixed real-estate budget face greater execution uncertainty.
Source: 2026 FDD, Items 7 and 10, pp. 11–21; Franchise Agreement Attachment I.
Training paired with full-time management
Verified fact: Initial training includes at least 39 classroom hours, while the owner, principal owner contact, or an approved trained manager must participate personally and full-time.
Potential advantageStructured onboarding may reduce setup ambiguity for operators without a prior healthcare background.
ConstraintPassive buyers must fund and supervise a qualified manager, travel, implementation work, and employee training.
Source: 2026 FDD, Items 11 and 15, pp. 21–33; Franchise Agreement §§8.01–8.04 and 12.03; official support and training overview.
Item 19 revenue evidence
Verified fact: Item 19 reports 2025 Gross Revenue for 213 franchised Stand-Alone Businesses by quartile and separately reports 17 continuously operating franchised Micro Market Businesses.
Potential advantageFormat-specific historical distributions give buyers more evidence than a single systemwide average.
ConstraintThe figures are unaudited Gross Revenue, exclude operating expenses, and use a small Micro Market sample.
Source: 2026 FDD, Item 19, pp. 37–40. Item 19 is not a profit, cash-flow, or owner-income representation.
Approved laboratories, MALT, and data access
Verified fact: Franchisees must use approved laboratories and designated systems including MALT, with ARCpoint Group supplying MALT services and the franchisor retaining broad access to business data.
Potential advantageApproved clinical and technology infrastructure may reduce vendor-selection and workflow-design ambiguity.
ConstraintBuyers seeking vendor choice, customer-data control, or predictable upgrade costs may experience friction.
Source: 2026 FDD, Items 8 and 11, pp. 16–27; Franchise Agreement §§11 and 12.06–12.17.
Centralized marketing with mandatory local execution
Verified fact: Stand-Alone and Micro Market operators have monthly local and pay-per-click minimums, contribute to the National Marketing Fund, and cannot independently control internet marketing.
Potential advantageCentral brand pages, approved campaigns, and shared creative may provide a defined marketing operating system.
ConstraintLocal-control buyers must accept fixed spending, approved vendors, content review, and non-proportional fund benefits.
Source: 2026 FDD, Items 6 and 11, pp. 7–10 and 24–26; Franchise Agreement §§9.02–9.07.
Territory protection with reserved channels
Verified fact: A compliant franchisee receives protection from another permanent Any Lab Test Now brick-and-mortar outlet inside the Territory, but the Territory is expressly nonexclusive.
Potential advantageThe same-mark storefront restriction gives location-based separation for buyers focused on local retail demand.
ConstraintInternet, national-account, alternative-channel, and other-mark activity can occur inside the Territory without compensation.
Source: 2026 FDD, Item 12, pp. 27–30; Franchise Agreement §§4.02–4.03; official available-markets page.
Long contract horizon and constrained exit
Verified fact: The Franchise Agreement runs 10 years with one potential 10-year renewal, while transfer, default, liquidated-damages, arbitration, and post-term noncompetition provisions limit unilateral exit flexibility.
Potential advantageA defined long-term license and approval-based transfer path may suit committed operators building durable local operations.
ConstraintShort-horizon buyers face renewal modernization, transfer conditions, Georgia dispute provisions, and two-year geographic restrictions.
Source: 2026 FDD, Item 17, pp. 33–37; Franchise Agreement §§3, 13–16; state addenda may modify enforceability.
Item 20 system evidence
What does the outlet history show about system direction?
Item 20 shows year-end system expansion across 2023–2025, with the affiliate-operated population unchanged. That trend provides network context, but it does not establish unit economics, franchisee satisfaction, or the quality of a specific territory.
Systemwide outlets at year-end
Each bar reconciles franchised and affiliate-operated Any Lab Test Now outlets.
Interpretation: Year-end totals increased by 14, 16, and 10 outlets in the three reported years. In 2025, Item 20 separately records 18 openings, eight outlets that ceased operations for “other reasons,” and 15 transfers; these categories should not be treated as equivalent outcomes.
Source: 2026 FDD, Item 20, Tables 1–4, pp. 40–45. Reporting dates are December 31, 2023, 2024, and 2025.
Item 19 evidence quality
How much decision value does the revenue disclosure provide?
The Stand-Alone quartiles show material dispersion rather than one representative outcome. Buyers can use the population and ranges to frame validation calls, but they still need labor, occupancy, laboratory, marketing, physician-processing, and local demand evidence to understand store-level economics.
2025 average Gross Revenue by Stand-Alone quartile
Population: 213 franchised Stand-Alone Businesses open continuously for the full 2025 reporting period.
Interpretation: The top-quartile average was more than three times the bottom-quartile average. This supports territory- and operator-specific diligence rather than a systemwide revenue assumption. Item 19 also reports 17 Micro Market Businesses separately, with average Gross Revenue of $137,230.
Source: 2026 FDD, Item 19, Sections 1 and 3, pp. 37–39. Gross Revenue data were derived from unaudited reports and exclude toxicology employer services.
Dual-edged evidence
Item 19 is comparatively useful because it separates Stand-Alone quartiles, Affiliate-Operated Businesses, and Micro Market Businesses. Its limitation is equally specific: it does not disclose store operating expenses or profit, and the seven Affiliate-Operated Businesses are not a substitute for franchised results. The official business-model page explains customer channels, but contractual and financial conclusions must remain anchored to the FDD.
Buyer-profile map
Which buyer profiles align with the operating and contract structure?
Fit depends less on prior medical credentials than on the ability to manage a regulated retail service, execute local demand generation, and accept the Franchise Agreement’s control allocation. The official franchise site states that healthcare experience is not required, while the FDD places legal compliance, staffing, and employee training responsibility on the franchisee.
Owner role
More aligned whenThe buyer will operate full-time or has capital and oversight capacity for a trained, approved manager.
More friction whenThe buyer expects passive ownership, minimal staff development, or limited involvement in daily compliance.
Control preference
More aligned whenThe buyer values specified laboratories, MALT workflows, centralized digital marketing, and defined System standards.
More friction whenThe buyer wants independent suppliers, unrestricted internet marketing, autonomous data use, or broad pricing discretion.
Growth path
More aligned whenA multi-unit buyer can fund scheduled development and preserve operating performance across separate Franchise Agreements.
More friction whenThe buyer wants optional expansion without a MUD Schedule, nonrefundable development fees, or cross-default exposure.
Time horizon
More aligned whenThe buyer expects a long operating horizon and can plan for modernization, renewal, transfer, and succession conditions.
More friction whenThe buyer needs an easy unilateral exit or intends to enter a competing laboratory-services business soon afterward.
Sources: 2026 FDD, Items 10–12, 15, and 17; Franchise Agreement §§3–16; MUD Agreement §§I–VII; official franchise model description.
Buyer verification
What should be verified before signing?
The highest-value diligence questions should convert disclosed systemwide terms into site-, format-, state-, and operator-specific evidence. The FTC recommends reviewing the FDD, agreements, financial statements, and current and former franchisee contacts rather than relying on sales presentations alone.
1
Obtain the completed Attachment I showing the exact Stand-Alone or Micro Market format, Territory boundaries, population basis, Premises, Initial Franchise Fee, and every negotiated term.
2
Reconcile the Micro Market investment-range discrepancy between the 2026 FDD and current official FAQ, including whether the quote is single-unit or multi-unit.
3
Request the current approved-supplier list and contracts for laboratories, MALT, SOCi, WooCommerce, Constant Contact, QuickBooks Online, pay-per-click vendors, merchant services, and physician-processing arrangements.
4
Model the full recurring obligation stack: royalty minimum, National Marketing Fund, local advertising, pay-per-click minimum, Technology Fee, insurance, lab costs, physician fees, staffing, and potential cooperative contributions.
5
Request Item 19 written substantiation and interview current and former franchisees across comparable quartiles, formats, markets, opening vintages, labor models, and occupancy profiles.
6
Review the National Marketing Fund’s 2025 statement and ask how location pages, lead routing, national accounts, alternative channels, referral fees, and revenue sharing would apply to the proposed Territory.
7
Confirm state-specific clinical authority, corporate-practice-of-medicine, physician-order, privacy, licensing, insurance, and data-breach requirements with qualified healthcare and franchise counsel.
8
Have counsel compare Item 17 with the signed Franchise Agreement, state addenda, lease, guaranty, noncompetition agreement, transfer conditions, liquidated damages, and Georgia arbitration provisions.
9
For a Multi-Unit Development Agreement, stress-test each MUD Schedule deadline, nonrefundable fee, site-approval dependency, required capital reserve, and consequence of missing a development date.
Conditional synthesis
What is the practical buyer takeaway?
Any Lab Test Now’s strongest verified structural advantage is a specified direct-access laboratory system with format-specific training, approved clinical relationships, centralized technology, and meaningful Item 19 segmentation. Its most material burden is the cumulative control and commitment package: full-time management, mandatory marketing, supplier and data dependencies, nonexclusive channel rights, and constrained exit.
The model is more aligned with a hands-on retail-services operator who accepts standardized systems and has capital for staffing, local demand generation, compliance, and contingencies. Friction is more likely for a passive buyer, a local-control buyer, or a short-horizon investor. Before signing, the highest-priority verification is the completed Territory and format package reconciled to current vendor, marketing, clinical, investment, and state-addendum terms.
